| 1 |
33300057 | The mRNA expression of Il6 and Pdcd1 are predictive and protective factors for doxorubicin‑induced cardiotoxicity. | 2021 Feb |
1 |
| 2 |
33482179 | Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis. | 2021 Mar 15 |
1 |
| 3 |
33556877 | Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation. | 2021 May |
1 |
| 4 |
34234834 | Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice. | 2021 |
1 |
| 5 |
34246743 | Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin. | 2021 Sep 5 |
1 |
| 6 |
34339076 | Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma-bearing mice. | 2021 Oct |
1 |
| 7 |
34711820 | Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy. | 2021 Oct 28 |
1 |
| 8 |
34734816 | Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway. | 2021 Nov |
2 |
| 9 |
34827723 | Role of Inflammation and Redox Status on Doxorubicin-Induced Cardiotoxicity in Infant and Adult CD-1 Male Mice. | 2021 Nov 19 |
1 |
| 10 |
31931676 | Doxorubicin modulated clock genes and cytokines in macrophages extracted from tumor-bearing mice. | 2020 Apr 2 |
2 |
| 11 |
33099539 | Interleukin-6 knockout reverses macrophage differentiation imbalance and alleviates cardiac dysfunction in aging mice. | 2020 Oct 25 |
3 |
| 12 |
33316945 | Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Muscle Toxicity through Counteracting Pyroptosis. | 2020 Dec 9 |
1 |
| 13 |
30734460 | Genistein protects against doxorubicin-induced cardiotoxicity through Nrf-2/HO-1 signaling in mice model. | 2019 May |
1 |
| 14 |
30936017 | Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury. | 2019 Jun |
1 |
| 15 |
31054317 | Improvement of chemotherapy through reducing of cachexia by using Citrus unshiu peel extract. | 2019 Oct 5 |
1 |
| 16 |
31744501 | Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators. | 2019 Nov 19 |
2 |
| 17 |
29228376 | Effects of Cyclophosphamide and/or Doxorubicin in a Murine Model of Postchemotherapy Cognitive Impairment. | 2018 Apr 1 |
1 |
| 18 |
29544808 | Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation. | 2018 May |
1 |
| 19 |
29682158 | Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress. | 2018 |
1 |
| 20 |
29753615 | Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity. | 2018 Aug |
1 |
| 21 |
29775573 | Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway. | 2018 Jun 25 |
1 |
| 22 |
29078883 | Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer. | 2017 Nov |
1 |
| 23 |
29617099 | A Second-Generation Proteasome Inhibitor and Doxorubicin Modulates IL-6, pSTAT-3 and NF-kB Activity in MDA-MB-231 Breast Cancer Cells. | 2017 Jan |
1 |
| 24 |
26603425 | Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice. | 2016 Jan |
1 |
| 25 |
26780402 | Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. | 2016 Feb 15 |
1 |
| 26 |
27444332 | The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity. | 2016 Jul 21 |
1 |
| 27 |
27547188 | S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice. | 2016 |
1 |
| 28 |
27566778 | A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. | 2016 Aug 15 |
1 |
| 29 |
25462173 | Chronic heart damage following doxorubicin treatment is alleviated by lovastatin. | 2015 Jan |
1 |
| 30 |
24799355 | Modulator effects of meloxicam against doxorubicin-induced nephrotoxicity in mice. | 2014 Aug |
1 |
| 31 |
26417320 | Scientific validation of cardioprotective attribute by standardized extract of Bombyx mori against doxorubicin-induced cardiotoxicity in murine model. | 2014 |
1 |
| 32 |
23114643 | Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin. | 2013 Jan |
1 |
| 33 |
23322372 | Preventive effects of ellagic acid against doxorubicin-induced cardio-toxicity in mice. | 2013 Sep |
1 |
| 34 |
22130157 | Cancer cells containing nanoscale chemotherapeutic drugs generate antiovarian cancer-specific CD4+ T cells in peritoneal space. | 2012 Jan |
1 |
| 35 |
23323011 | Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice. | 2012 Dec 21 |
1 |
| 36 |
21464611 | Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome. | 2011 Jun 15 |
2 |
| 37 |
21920376 | p21(WAF1/Cip1/Sdi1) knockout mice respond to doxorubicin with reduced cardiotoxicity. | 2011 Nov 15 |
2 |
| 38 |
19066339 | Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice. | 2009 Mar |
1 |
| 39 |
18627295 | Doxorubicin cardiomyopathy-induced inflammation and apoptosis are attenuated by gene deletion of the kinin B1 receptor. | 2008 Jun |
1 |
| 40 |
12698271 | Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. | 2003 Jul |
1 |